Every time investors think Valeant Pharmaceuticals has hit rock bottom, the company finds a way to prove them wrong.
But if they'd kept an eye out for these signs, they could have bypassed this entire train wreck.
By Michael E. Lewitt, Global Credit Strategist, Money Morning • @MichaelELewitt -
Every time investors think Valeant Pharmaceuticals has hit rock bottom, the company finds a way to prove them wrong.
But if they'd kept an eye out for these signs, they could have bypassed this entire train wreck.
Watch for these signals to avoid bad investments like Valeant...
By Michael E. Lewitt, Global Credit Strategist, Money Morning • @MichaelELewitt -
Every time investors think Valeant Pharmaceuticals has hit rock bottom, the company finds a way to prove them wrong.
But if they'd kept an eye out for these signs, they could have bypassed this entire train wreck.
Watch for these signals to avoid bad investments like Valeant...
By David Zeiler, Associate Editor, Money Morning • @DavidGZeiler -
GoPro stock was a disaster waiting to happen, even before an Apple Inc. (Nasdaq: AAPL) patent for a remote control camera went public yesterday (Tuesday).
That's because despite its cool technology, GoPro Inc. (Nasdaq: GPRO) faced an array of threats. Money Morning has been warning investors about this company since last summer.